Medical News

Even before the start of the American Diabetes Association’s (ADA) 80th Scientific Sessions, dapagliflozin was one ... read more
Results of a phase 2 trial examining a CXCR1/2 inhibitor in adult patients with new-onset type ... read more
New research may lead way to understanding the potential triggers of the autoimmune process leading to ... read more
Compliance with continuous positive airway pressure treatment in patients with type 2 diabetes and obstructive sleep ... read more
The impact of the coronavirus disease 2019 (COVID-19) outbreak on endocrinology has been impossible to ignore. With ... read more
The US Food and Drug Administration (FDA) has cleared Abbott’s FreeStyle Libre 2 integrated continuous glucose ... read more
A new analysis from an international team of investigators presented at the American Diabetes Association’s (ADA) ... read more
A new analysis of nondiabetic patients from the landmark DAPA-HF trial suggests use of dapagliflozin could ... read more